The US arm of Sun Pharmaceutical Industries is recalling over 2,500 bottles of Metformin hydrochloride extended release tablets from Arizona on account of presence of foreign substance in one lot.
United States Food and Drug Administration (USFDA) said the company is recalling 2,508 bottles of Metformin hydrochloride extended release tablets 500 mg, packaged in a 500-count bottle.
The reason for recall is presence of foreign substance—one lot of these tablets contains foreign matter identified as a piece of rubber glove detected in one tablet, it added.
The tablets were manufactured at Sun Pharma’s Halol facility, USFDA said in its Enforcement report. The ongoing, voluntary recall is a class II recall, it added.
According to USFDA, a class II recall is initiated in a situation “in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
Metformin hydrochloride extended release tablets are used to improve glycemic control in adults with type 2 diabetes.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.